Condition: Validation of Vital Signs Measured by a Consumer-grade Smartwatch · Sponsor: Ziekenhuis Oost-Limburg
This clinical trial evaluates the accuracy of the Garmin Venu 3 / Garmin Venu 4 smartwatch in measuring vital signs (heart rate, respiratory rate, SpO₂) compared to the clinically validated Philips IntelliVue X2. The study aims to determine whether the consumer-grade smartwatch can provide reliable data for remote patient monitoring, early hospital discharge, and chronic disease management, offering a more accessible and affordable alternative to MDR-certified devices.
This description comes directly from the study's public registry record.
Ruben Knevels, MSc · +32 89 80 40 29 · ruben.knevels@zol.be
Femke Wouters, PhD · +32 89 80 40 32 · femke.wouters@zol.be
Always discuss trial participation with your own doctor first.
| Ziekenhuis Oost-Limburg | Genk, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07360678